Skip to main content
. 2021 Oct 20;29(4):434–442. doi: 10.5606/tgkdc.dergisi.2021.22110

Table 5. Renal outcomes between the patient groups.

Variables Fixation type p
Suprarenal (n=114) Infrarenal (n=54)
n % Mean±SD n % Mean±SD
Baseline insufficiency (sCr >1.5 mg/dL) 6 5.3   2 3.7   0.660
Post-EVAR renal impairment (>30%)              
Change in sCr level 57 50   28 51.9   0.824
Change in MDRD 53 46.5   26 48.1   0.842
Change in Crockcroft-Gault 50 43.9   20 37   0.405
Change in CKD-EPI 33 28.9   15 27.8   0.876
Hemodialysis 2 1.8   0 0   0.330
Contrast volume (mL)     231±24.2     225±25.2 0.107
Renal artery stenosis/stent 2 1.8   0 0   0.330
Renal infarction 3 2.6   1 1.9   0.759
Computed tomography (n)     4.63±2.58     4.12±2.23 0.221
SD: Standard deviation; EVAR: Endovascular aortic repair; MDRD: Modification of Diet in Renal Disease; sCr: Serum creatinine; CKD-EPI: Chronic Kidney Disease-Epidemiology Collaboration.